Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
复制标题
多发性内分泌肿瘤中的胰腺胰岛素瘤,I型基因敲除小鼠可以在没有染色体不稳定或微卫星不稳定的情况下发生。
DOI:
10.1158/0008-5472.can-04-1648
复制
发表时间:
2004
期刊:
影响因子:
11.2
通讯作者:
Collins,FrancisS
中科院分区:
文献类型:
--
作者:
Scacheri,PeterC;Kennedy,AlyssaL;Chin,Koei;Miller,MeghanT;Hodgson,JGraeme;Gray,JoeW;Marx,StephenJ;Spiegel,AllenM;Collins,FrancisS
Multiple endocrine neoplasia, type I (MEN1) is an inherited cancer syndrome characterized by tumors arising primarily in endocrine tissues. The responsible gene acts as a tumor suppressor, and tumors in affected heterozygous individuals occur after inactivation of the wild-type allele. Previous studies have shown thatMen1knockout mice develop multiple pancreatic insulinomas, but this occurs many months after loss of both copies of theMen1gene. These studies imply that loss ofMen1is not alone sufficient for tumor formation and that additional somatic genetic changes are most likely essential for tumorigenesis. The usual expectation is that such mutations would arise either by a chromosomal instability or microsatellite instability mechanism. In a study of more then a dozen such tumors, using the techniques of array-based comparative genomic hybridization, fluorescentin situhybridization, loss of heterozygosity analysis using multiple microsatellite markers across the genome, and real time PCR to assess DNA copy number, it appears that many of these full-blown clonal adenomas remain remarkably euploid. Furthermore, the loss of the wild-typeMen1allele in heterozygousMen1mice occurs by loss and reduplication of the entire mutant-bearing chromosome. Thus, the somatic genetic changes that are postulated to lead to tumorigenesis in a mouse model of MEN1 must be unusually subtle, occurring at either the nucleotide level or through epigenetic mechanisms.